#Oncology

Adaptam Therapeutics Funding Targets Tough Cancer Immunotherapy Challenge

Treeline Biosciences Raises $200M, Initiates Clinical Trials

The company also initiated Phase 1 trials for three oncology programs, including a pan-KRAS inhibitor.

Evaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized cancer vaccine EVX-01

Breakthrough Discovery by Cancer 3D Shows Tumors Behave as Invasive Networks

RISA Labs Raises $3.5M to Eliminate Treatment Delays with AI-Powered Workflow Automation in Oncology

\n Cancer patients don’t just fight the disease - they fight the system. Today, life-saving treatments are routinely delayed by days or even weeks due to manual...

RISA Labs Raises $3.5M to Eliminate Treatment Delays with AI-Powered Workflow Automation in Oncology

\n Cancer patients don’t just fight the disease - they fight the system. Today, life-saving treatments are routinely delayed by days or even weeks due to manual...

Triomics Raises $15M to Automate Oncology Workflows with GenAI Platform

C2i Genomics Acquired for $95 Million by Veracyte

Ibex Medical Analytics Secures $55 Million Series C Funding for AI Cancer Diagnostics

FORE Biotherapeutics Secures $75 Million Funding Co-led by SR One and Medicxi

Immunai and Baylor College of Medicine Unveil BTG1 as New Molecular Target to Boost Cancer Immunotherapy

Belong.Life Unveils World's First LLM-Powered Oncology Mentor, Dave

Pangea Biomed Extends Seed Round by $5 Million for its Multi-Cancer Response Predictor Technology